Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo.

Hampton DW, Asher RA, Kondo T, Steeves JD, Ramer MS, Fawcett JW.

Eur J Neurosci. 2007 Dec;26(11):3024-35.

PMID:
18028109
2.

How does chondroitinase promote functional recovery in the damaged CNS?

Crespo D, Asher RA, Lin R, Rhodes KE, Fawcett JW.

Exp Neurol. 2007 Aug;206(2):159-71. Epub 2007 May 8. Review.

PMID:
17572406
3.

Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair.

Galtrey CM, Asher RA, Nothias F, Fawcett JW.

Brain. 2007 Apr;130(Pt 4):926-39. Epub 2007 Jan 25.

PMID:
17255150
4.

Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro.

Asher RA, Morgenstern DA, Properzi F, Nishiyama A, Levine JM, Fawcett JW.

Mol Cell Neurosci. 2005 May;29(1):82-96.

PMID:
15866049
5.

Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia.

Properzi F, Carulli D, Asher RA, Muir E, Camargo LM, van Kuppevelt TH, ten Dam GB, Furukawa Y, Mikami T, Sugahara K, Toida T, Geller HM, Fawcett JW.

Eur J Neurosci. 2005 Jan;21(2):378-90.

PMID:
15673437
6.

The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathways.

Shearer MC, Niclou SP, Brown D, Asher RA, Holtmaat AJ, Levine JM, Verhaagen J, Fawcett JW.

Mol Cell Neurosci. 2003 Dec;24(4):913-25.

PMID:
14697658
7.

Expression and glycanation of the NG2 proteoglycan in developing, adult, and damaged peripheral nerve.

Morgenstern DA, Asher RA, Naidu M, Carlstedt T, Levine JM, Fawcett JW.

Mol Cell Neurosci. 2003 Nov;24(3):787-802.

PMID:
14664826
8.

Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury.

Properzi F, Asher RA, Fawcett JW.

Biochem Soc Trans. 2003 Apr;31(2):335-6. Review.

PMID:
12653631
10.

Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase.

Moon LD, Asher RA, Fawcett JW.

J Neurosci Res. 2003 Jan 1;71(1):23-37.

PMID:
12478611
11.

Chondroitin sulphate proteoglycans in the CNS injury response.

Morgenstern DA, Asher RA, Fawcett JW.

Prog Brain Res. 2002;137:313-32. Review.

PMID:
12440375
12.

Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells.

Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW.

J Neurosci. 2002 Mar 15;22(6):2225-36.

13.
14.

Chondroitin sulphate proteoglycans: inhibitory components of the glial scar.

Asher RA, Morgenstern DA, Moon LD, Fawcett JW.

Prog Brain Res. 2001;132:611-9. Review. No abstract available.

PMID:
11545024
15.

Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC.

Moon LD, Asher RA, Rhodes KE, Fawcett JW.

Nat Neurosci. 2001 May;4(5):465-6. No abstract available.

PMID:
11319553
16.

Neurocan is upregulated in injured brain and in cytokine-treated astrocytes.

Asher RA, Morgenstern DA, Fidler PS, Adcock KH, Oohira A, Braistead JE, Levine JM, Margolis RU, Rogers JH, Fawcett JW.

J Neurosci. 2000 Apr 1;20(7):2427-38.

17.
18.

Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2.

Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, Muir E, Levine JM, Geller HM, Rogers JH, Faissner A, Fawcett JW.

J Neurosci. 1999 Oct 15;19(20):8778-88.

19.

The glial scar and central nervous system repair.

Fawcett JW, Asher RA.

Brain Res Bull. 1999 Aug;49(6):377-91. Review.

PMID:
10483914
20.

Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican?

Perides G, Asher RA, Lark MW, Lane WS, Robinson RA, Bignami A.

Biochem J. 1995 Dec 1;312 ( Pt 2):377-84.

21.

On the existence of a cartilage-like proteoglycan and link proteins in the central nervous system.

Asher RA, Scheibe RJ, Keiser HD, Bignami A.

Glia. 1995 Apr;13(4):294-308.

PMID:
7615338
22.

Isolation of a large aggregating proteoglycan from human brain.

Perides G, Rahemtulla F, Lane WS, Asher RA, Bignami A.

J Biol Chem. 1992 Nov 25;267(33):23883-7.

23.

A bacteriolytic muramidase from the basidiomycete Schizophyllum commune.

Grant WD, Prosser BA, Asher RA.

J Gen Microbiol. 1990 Nov;136(11):2267-73.

PMID:
2127798
24.

Oxidation of Lignin-Related Aromatic Alcohols by Cell Suspensions of Methylosinus trichosporium.

Mountfort DO, White D, Asher RA.

Appl Environ Microbiol. 1990 Jan;56(1):245-9.

25.

Production of xylanase by the ruminal anaerobic fungus Neocallimastix frontalis.

Mountfort DO, Asher RA.

Appl Environ Microbiol. 1989 Apr;55(4):1016-22.

26.

Production of alpha-Amylase by the Ruminal Anaerobic Fungus Neocallimastix frontalis.

Mountfort DO, Asher RA.

Appl Environ Microbiol. 1988 Sep;54(9):2293-9.

27.
28.

Inhibition of the methylcoenzyme M methylreductase system by NAD+ and NADP+ in cell-extracts of Methanosarcina barkeri.

Mountfort DO, Asher RA.

Biochem Biophys Res Commun. 1984 Aug 30;123(1):238-46.

PMID:
6433916
30.

The dangers of going to bed.

Asher RA.

Crit Care Update. 1983 May;10(5):40-1, 51. No abstract available.

PMID:
6554145
33.

Carbon and electron flow in mud and sandflat intertidal sediments at delaware inlet, nelson, new zealand.

Mountfort DO, Asher RA, Mays EL, Tiedje JM.

Appl Environ Microbiol. 1980 Apr;39(4):686-94.

34.
36.

The maintenance therapy of pernicious anaemia with vitamin B12.

BREWERTON DA, ASHER RA.

Lancet. 1952 Aug 9;2(6728):265-6. No abstract available.

PMID:
14947004
37.

Myxoedema.

ASHER RA.

Med Illus. 1951 Aug;5(8):388-94. No abstract available.

PMID:
14862770
38.

The dangers of going to bed.

ASHER RA.

Br Med J. 1947 Dec 13;2(4536):967. No abstract available.

Supplemental Content

Loading ...
Support Center